JPH01172341A - Preventive and remedy for infectious disease of clostridium perfringens of domestic animal and domestic fowl - Google Patents
Preventive and remedy for infectious disease of clostridium perfringens of domestic animal and domestic fowlInfo
- Publication number
- JPH01172341A JPH01172341A JP62328331A JP32833187A JPH01172341A JP H01172341 A JPH01172341 A JP H01172341A JP 62328331 A JP62328331 A JP 62328331A JP 32833187 A JP32833187 A JP 32833187A JP H01172341 A JPH01172341 A JP H01172341A
- Authority
- JP
- Japan
- Prior art keywords
- rhizome
- crude drug
- root
- leaves
- linne
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003449 preventive effect Effects 0.000 title abstract description 8
- 208000015181 infectious disease Diseases 0.000 title description 19
- 241001465754 Metazoa Species 0.000 title description 12
- 208000035473 Communicable disease Diseases 0.000 title description 4
- 241000193468 Clostridium perfringens Species 0.000 title description 3
- 239000003814 drug Substances 0.000 claims abstract description 45
- 229940079593 drug Drugs 0.000 claims abstract description 26
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 10
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 10
- 244000025221 Humulus lupulus Species 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 7
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 7
- 239000004615 ingredient Substances 0.000 claims description 26
- 239000000284 extract Substances 0.000 claims description 22
- 241000411851 herbal medicine Species 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 241000282887 Suidae Species 0.000 claims description 16
- 244000144977 poultry Species 0.000 claims description 16
- 235000013594 poultry meat Nutrition 0.000 claims description 16
- 244000144972 livestock Species 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 239000003960 organic solvent Substances 0.000 claims description 14
- 229940124597 therapeutic agent Drugs 0.000 claims description 13
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 11
- 240000006891 Artemisia vulgaris Species 0.000 claims description 11
- 241000218671 Ephedra Species 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 230000002265 prevention Effects 0.000 claims description 11
- 230000000069 prophylactic effect Effects 0.000 claims description 11
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 10
- 244000299790 Rheum rhabarbarum Species 0.000 claims description 10
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 10
- 241000287828 Gallus gallus Species 0.000 claims description 9
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 9
- 240000002657 Thymus vulgaris Species 0.000 claims description 9
- 239000001585 thymus vulgaris Substances 0.000 claims description 9
- 241001116389 Aloe Species 0.000 claims description 8
- 241000555712 Forsythia Species 0.000 claims description 8
- 235000005491 Geranium thunbergii Nutrition 0.000 claims description 8
- 244000105059 Geranium thunbergii Species 0.000 claims description 8
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 8
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 8
- 235000011399 aloe vera Nutrition 0.000 claims description 8
- 235000013330 chicken meat Nutrition 0.000 claims description 8
- 229940010454 licorice Drugs 0.000 claims description 8
- 241000283690 Bos taurus Species 0.000 claims description 7
- 208000037384 Clostridium Infections Diseases 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 241000207199 Citrus Species 0.000 claims description 4
- 235000020971 citrus fruits Nutrition 0.000 claims description 4
- 241001494479 Pecora Species 0.000 claims description 3
- 244000197975 Solidago virgaurea Species 0.000 claims description 3
- 235000000914 Solidago virgaurea Nutrition 0.000 claims description 3
- 244000170916 Paeonia officinalis Species 0.000 claims 2
- 244000068988 Glycine max Species 0.000 claims 1
- 235000010469 Glycine max Nutrition 0.000 claims 1
- 244000184734 Pyrus japonica Species 0.000 abstract description 7
- 235000013399 edible fruits Nutrition 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 241000894006 Bacteria Species 0.000 abstract description 5
- 235000008694 Humulus lupulus Nutrition 0.000 abstract description 4
- 241000612118 Samolus valerandi Species 0.000 abstract description 4
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 235000004509 Aloe arborescens Nutrition 0.000 abstract description 2
- 240000007474 Aloe arborescens Species 0.000 abstract description 2
- 244000132436 Myrica rubra Species 0.000 abstract description 2
- 244000124853 Perilla frutescens Species 0.000 abstract description 2
- 241001530126 Scrophularia Species 0.000 abstract description 2
- 241000218203 Coptis japonica Species 0.000 abstract 2
- 241000723347 Cinnamomum Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000008375 Decussocarpus nagi Nutrition 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 244000275701 Geranium nepalense Species 0.000 abstract 1
- 241000201320 Ligustrum japonicum Species 0.000 abstract 1
- 240000004580 Magnolia hypoleuca Species 0.000 abstract 1
- 235000014631 Myrica rubra Nutrition 0.000 abstract 1
- 241001529733 Nepeta Species 0.000 abstract 1
- 235000004348 Perilla frutescens Nutrition 0.000 abstract 1
- 241000972673 Phellodendron amurense Species 0.000 abstract 1
- 240000001745 Rheum palmatum Species 0.000 abstract 1
- 235000008090 Rheum palmatum Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 210000003813 thumb Anatomy 0.000 abstract 1
- 239000000047 product Substances 0.000 description 35
- 241000282412 Homo Species 0.000 description 31
- 238000012360 testing method Methods 0.000 description 21
- 201000010099 disease Diseases 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 241000193403 Clostridium Species 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 206010012735 Diarrhoea Diseases 0.000 description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 241000736199 Paeonia Species 0.000 description 8
- 239000002221 antipyretic Substances 0.000 description 8
- 239000002934 diuretic Substances 0.000 description 8
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 8
- -1 hot bath Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 230000000202 analgesic effect Effects 0.000 description 7
- 239000003242 anti bacterial agent Substances 0.000 description 7
- 230000001754 anti-pyretic effect Effects 0.000 description 7
- 239000001648 tannin Substances 0.000 description 7
- 229920001864 tannin Polymers 0.000 description 7
- 235000018553 tannin Nutrition 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000001882 diuretic effect Effects 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 241000209020 Cornus Species 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 206010061043 Clostridial infection Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 230000000954 anitussive effect Effects 0.000 description 4
- 229940124584 antitussives Drugs 0.000 description 4
- 239000007799 cork Substances 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 231100000517 death Toxicity 0.000 description 4
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000004515 gallic acid Nutrition 0.000 description 4
- 229940074391 gallic acid Drugs 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 235000017709 saponins Nutrition 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 235000017519 Artemisia princeps Nutrition 0.000 description 3
- 244000065027 Artemisia princeps Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 244000061408 Eugenia caryophyllata Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 description 3
- 241000218228 Humulus Species 0.000 description 3
- 240000007695 Nandina domestica Species 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 241000122594 Salvia ringens Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 230000002921 anti-spasmodic effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000000812 cholinergic antagonist Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000000321 herbal drug Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000008141 laxative Substances 0.000 description 3
- 230000002475 laxative effect Effects 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000001624 sedative effect Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- MJPMPMZXJIZPRE-UHFFFAOYSA-N 3-butyl-5,6,7,7a-tetrahydro-3h-2-benzofuran-1-one Chemical compound C1CCC=C2C(CCCC)OC(=O)C21 MJPMPMZXJIZPRE-UHFFFAOYSA-N 0.000 description 2
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- SCCDQYPEOIRVGX-UHFFFAOYSA-N Acetyleugenol Chemical compound COC1=CC(CC=C)=CC=C1OC(C)=O SCCDQYPEOIRVGX-UHFFFAOYSA-N 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- 241001124076 Aphididae Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 206010004053 Bacterial toxaemia Diseases 0.000 description 2
- KUJLPCYCQICVRM-UHFFFAOYSA-N Capillarin Chemical compound C1=CC=C2C(=O)OC(CC#CC)=CC2=C1 KUJLPCYCQICVRM-UHFFFAOYSA-N 0.000 description 2
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- 201000006082 Chickenpox Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 241001369972 Deudorix epijarbas Species 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 239000010282 Emodin Substances 0.000 description 2
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 2
- XOBKSJJDNFUZPF-UHFFFAOYSA-N Methoxyethane Chemical compound CCOC XOBKSJJDNFUZPF-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 2
- 240000006394 Sorghum bicolor Species 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000009430 Thespesia populnea Nutrition 0.000 description 2
- 208000013222 Toxemia Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 206010046980 Varicella Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 230000000507 anthelmentic effect Effects 0.000 description 2
- 230000002686 anti-diuretic effect Effects 0.000 description 2
- 229940124599 anti-inflammatory drug Drugs 0.000 description 2
- 239000000729 antidote Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- AKGGYBADQZYZPD-UHFFFAOYSA-N benzylacetone Chemical compound CC(=O)CCC1=CC=CC=C1 AKGGYBADQZYZPD-UHFFFAOYSA-N 0.000 description 2
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 2
- 229940093265 berberine Drugs 0.000 description 2
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 2
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 2
- 208000029182 enterotoxemia Diseases 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- 210000003746 feather Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- IQZZFVDIZRWADY-UHFFFAOYSA-N isocoumarin Chemical compound C1=CC=C2C(=O)OC=CC2=C1 IQZZFVDIZRWADY-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- RUMOYJJNUMEFDD-UHFFFAOYSA-N perillyl aldehyde Chemical compound CC(=C)C1CCC(C=O)=CC1 RUMOYJJNUMEFDD-UHFFFAOYSA-N 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 229930007105 (-)-alpha-thujone Natural products 0.000 description 1
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- APQIUTYORBAGEZ-UHFFFAOYSA-N 1,1-dibromoethane Chemical compound CC(Br)Br APQIUTYORBAGEZ-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- IBZHZDLSDSYDAW-UHFFFAOYSA-N 3-methoxy-4-phenylbutan-2-one Chemical compound COC(C(C)=O)CC1=CC=CC=C1 IBZHZDLSDSYDAW-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241001504639 Alcedo atthis Species 0.000 description 1
- 235000003840 Amygdalus nana Nutrition 0.000 description 1
- 244000296825 Amygdalus nana Species 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 241000271309 Aquilaria crassna Species 0.000 description 1
- 241000480037 Argyrosomus japonicus Species 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 1
- 235000002657 Artemisia tridentata Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 208000031729 Bacteremia Diseases 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000283725 Bos Species 0.000 description 1
- OWNRRUFOJXFKCU-UHFFFAOYSA-N Bromadiolone Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1C(O)CC(C=1C(OC2=CC=CC=C2C=1O)=O)C1=CC=CC=C1 OWNRRUFOJXFKCU-UHFFFAOYSA-N 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000006719 Cassia obtusifolia Nutrition 0.000 description 1
- 244000277285 Cassia obtusifolia Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000418885 Cyrtorchis ringens Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241001198931 Forsythia japonica Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 241000756137 Hemerocallis Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000519695 Ilex integra Species 0.000 description 1
- 241001183967 Isodon Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 102000001621 Mucoproteins Human genes 0.000 description 1
- 108010093825 Mucoproteins Proteins 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- 208000026344 Nasal disease Diseases 0.000 description 1
- 241000275031 Nica Species 0.000 description 1
- 208000030880 Nose disease Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241001024099 Olla Species 0.000 description 1
- 241001474977 Palla Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241000015864 Protobothrops flavoviridis Species 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 241000269841 Thunnus albacares Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- WNFXUXZJJKTDOZ-HNNXBMFYSA-N [(1s)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] acetate Chemical compound C1=CC(O)=C2C(=O)C([C@@H](OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-HNNXBMFYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000012675 alcoholic extract Substances 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N alpha-thujone Natural products CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229940017545 cinnamon bark Drugs 0.000 description 1
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 231100000544 menstrual irregularity Toxicity 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229940028444 muse Drugs 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- DCYOADKBABEMIQ-OWMUPTOHSA-N myricitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=C(O)C=2)OC2=CC(O)=CC(O)=C2C1=O DCYOADKBABEMIQ-OWMUPTOHSA-N 0.000 description 1
- DCYOADKBABEMIQ-FLCVNNLFSA-N myricitrin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1)C1=C(c2cc(O)c(O)c(O)c2)Oc2c(c(O)cc(O)c2)C1=O DCYOADKBABEMIQ-FLCVNNLFSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000010330 ougon Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- 235000014774 prunus Nutrition 0.000 description 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- WNFXUXZJJKTDOZ-UHFFFAOYSA-N shikonin acetate Natural products C1=CC(O)=C2C(=O)C(C(OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-UHFFFAOYSA-N 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- USMNOWBWPHYOEA-MRTMQBJTSA-N α-thujone Chemical compound O=C([C@@H]1C)C[C@@]2(C(C)C)[C@@H]1C2 USMNOWBWPHYOEA-MRTMQBJTSA-N 0.000 description 1
Landscapes
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、家畜及び家禽のクロストリジウムパーフリン
ゲンス感染症の予防及び治療剤に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a prophylactic and therapeutic agent for Clostridium perfringens infections in livestock and poultry.
さらに詳しくは、本発明は生薬を主成分とする鶏、豚、
牛、羊のクロストリジウム パーフリンゲンス感染症の
予防及び治療剤に関する。More specifically, the present invention provides chicken, pig,
This invention relates to a prophylactic and therapeutic agent for Clostridium perfringens infections in cattle and sheep.
また本発明は、生薬を投与することからなる同感染症の
予防及び治療方法に関する。The present invention also relates to a method for preventing and treating the same infectious disease, which comprises administering crude drugs.
[従来の技術]
家畜及び家禽のクロストリジウム バーフリンゲンス感
染症は、ClosLridium perl’r1ng
ensの感染によって起こる疾病で、代表的な症状とし
て壊厄性腸炎があり、またエンテロトキセミア、悪性水
腫の原因にもなる。罹病率、致死率がともに高(、養鶏
、ブロイラー、養豚、酪農業界に与える経済的被害は大
きい。従って、家畜及び家禽の数ある疾病の中でもその
防除対策の確立が急がれる最も重要な疾病の1つである
。[Prior Art] Clostridium perfringens infection of livestock and poultry is caused by ClosLridium perl'r1ng.
It is a disease caused by infection with E. ens, and the typical symptom is necrotic enteritis, and it can also cause enterotoxemia and malignant edema. Both morbidity and mortality rates are high (and the economic damage it causes to the poultry, broiler, pig, and dairy industries is significant. Therefore, among the many diseases of livestock and poultry, it is the most important disease for which it is urgently necessary to establish control measures. It is one of the.
壊痕性腸炎は、子豚、ヒナ等の疾病臨床的には下痢がみ
られ、腸粘膜への細菌の侵入、小腸の壊死を伴うことを
特徴とする。Scarring enteritis is a disease of piglets, chicks, etc. Clinically, diarrhea is observed, and it is characterized by bacterial invasion of the intestinal mucosa and necrosis of the small intestine.
エンテロトキセミアは、クロストリジウムバーフリンゲ
ンスが動物の小腸内で増殖し、その産生ずる毒素により
、壊死性、出血性の病変を起こし、かつ毒血症のために
急性死を招く疾病である。Enterotoxemia is a disease in which Clostridium verfringens proliferates in the small intestine of animals, and the toxins it produces cause necrotic and hemorrhagic lesions, and acute death due to toxemia.
悪性水腫は、偶発的または外科手術により生じた創面に
、菌が侵入して発生し、その菌が発芽、増殖して毒素を
出し、毒血症、菌血症を起こし死に至らせる疾病である
。Malignant dropsy is a disease that occurs when bacteria invade the wound surface caused by an accidental or surgical operation, and the bacteria germinate, multiply, and release toxins, causing toxemia and bacteremia, which can lead to death. .
このように、クロストリジウム バーフリンゲンス感染
症は、重大な伝染病であるにもかかわらず、予防・治療
方法が未だ確立されていない。Thus, although Clostridium verfringens infection is a serious infectious disease, preventive and therapeutic methods have not yet been established.
予防方法として、飼育管理を適当に行なうことなどが行
なわれているが、実際には予防は極めて困難である。Proper breeding management has been used as a prevention method, but in reality prevention is extremely difficult.
また、これまでに水痘を予防及び治療するために、抗生
物質やその他の抗菌剤を飼料とともに投与する方法も行
なわれている。しかし、近年、特に耐性菌の発生や食肉
への抗生物質等の残留性の問題などがあって、抗生物質
などの投与を動物に対して行なうことは適当ではないと
いう気運が高まりつつある。従って、抗生物質などを用
いない水痘の予防及び治療方法と予防及び治療剤の開発
が望まれている。Furthermore, in order to prevent and treat chickenpox, methods have been used to administer antibiotics and other antibacterial agents together with feed. However, in recent years, there has been a growing trend that it is not appropriate to administer antibiotics to animals due to problems such as the emergence of resistant bacteria and the persistence of antibiotics in meat. Therefore, it is desired to develop methods and agents for preventing and treating chickenpox that do not use antibiotics or the like.
[問題点を解決するための手段]
本発明者らは、上記の問題点を解決すべく研究した結果
、ある種の生薬に本疾病を抑制する効果がある事を見出
し、本発明を完成させた。[Means for Solving the Problems] As a result of research to solve the above problems, the present inventors discovered that certain herbal medicines have the effect of suppressing this disease, and completed the present invention. Ta.
即ち、本発明の目的は、家畜及び家禽のクロストリジウ
ム バーフリンゲンス感染症の予防及び治療剤並びに同
庁の予防及び治療方法を提供することにある。That is, an object of the present invention is to provide a preventive and therapeutic agent for Clostridium verfringens infection in livestock and poultry, and a preventive and therapeutic method according to the same agency.
本発明は、カンゾウ、ヨモギ、オウレン、オウゴン、オ
ウバク、ゲンノショウコ、コウボク、タンジン、チモ、
ダイオウ、チョウジ、ジョテイ、ケイガイ、ケイヒ、ゲ
ンジン、ケツメイシ、ビワヨウ、ボウフウ、ホップ、ソ
ヨウ、ヨウバイヒ、レンギヨウ、アロエ、ギュウタン、
イレイセン、ウバイ、エンメイソウ、シャゼンソウ、シ
ンイ、インチンコウ、ジンコウ、センキュウ、コウホン
、ゴバイシ、サンシュユ、シコン、コオウレン、シャク
ヤク、キンオウシ、タイム、シロナンテン、チユ及びマ
オウからなる群から選択された1種または2種以上の生
薬を含有する家畜及び家禽のクロストリジウム バーフ
リンゲンス感染症の予防及び治療剤を提供するものであ
る。The present invention covers licorice, mugwort, oren, scutellariae, scutellariae, gennoshoko, sardines, tanjin, chimo,
Rhubarb, clove, jotei, keigai, keihi, genjin, ketsumeishi, biwayo, boufuu, hop, soyo, youbaihi, forsythia, aloe, gyutan,
One or more species selected from the group consisting of Ireisen, Ubai, Enmeisou, Shazensou, Shin'ui, Inchinko, Jinkou, Senkyu, Kouhon, Gobaishi, Cornus elegans, Shikon, Kooren, Peony, Golden oxen, Thyme, White nandina, Chiyu, and Ephedra. The present invention provides a preventive and therapeutic agent for Clostridium verfringens infection in livestock and poultry, which contains the herbal medicine.
本発明はまた原末の形態の生薬、有機溶剤、有機溶剤と
水との混合物または水で抽出して得られる生薬エキス、
または生薬有効成分を含有する家畜及び家禽の同疾病の
予防及び治療剤を提供するものである。The present invention also relates to crude drugs in the form of bulk powders, organic solvents, mixtures of organic solvents and water, or crude drug extracts obtained by extraction with water;
Alternatively, the present invention provides a preventive and therapeutic agent for the same disease in livestock and poultry containing an active ingredient of a crude drug.
さらに本発明は、カンゾウ、ヨモギ、オウレン、オウゴ
ン、オウバク、ゲンノショウコ、コウボク、タンジン、
チモ、ダイオウ、チョウジ、ジョテイ、ケイガイ、ケイ
ヒ、ゲンジン、ケツメイシ、ビワヨウ、ボウフウ、ホッ
プ、ソヨウ、ヨウバイヒ、レンギヨウ、アロエ、ギュウ
タン、イレイセン、ウバイ、エンメイソウ、シャゼンソ
ウ、シンイ、インチンコウ、ジンコウ、センキュウ、コ
ウホン、ゴバイシ、サンシュユ、シコン、コオウレン、
シャクヤク、キンオウシ、タイム、シロナンテン、チユ
及びマオウからなる群から選択された1種または2種以
上の生薬の有効量を投与することからなる家畜及び家禽
の同疾病の予防及び治療方法を提供するものである。Furthermore, the present invention provides licorice, mugwort, oren, scutellariae, scutellariae, gennoshoko, staghorn, tanjin,
Chimo, rhubarb, clove, jotei, kegai, keihi, genjin, ketsumeishi, biwayo, boufuu, hop, soyou, youbaihi, forsythia, aloe, gyutan, ireisen, ubai, japonica, shazenso, shinii, inchinko, jinkou, senkyu, kouhon, Gobaishi, Cornelius, Shikon, Koouren,
To provide a method for preventing and treating the same disease in livestock and poultry, which comprises administering an effective amount of one or more crude drugs selected from the group consisting of peonies, goldenrod, thyme, whitenanthene, chiyu, and ephedra. It is.
本発明はまた、原末の形態の生薬、有機溶剤、有機溶剤
と水との混合物または水で抽出して得られる生薬エキス
、または生薬有効成分の形態で投与することからなる哺
乳類の同疾病の予防及び治療方法を提供するものである
。The present invention also provides treatment for the same disease in mammals by administering crude drugs in the form of bulk powders, organic solvents, mixtures of organic solvents and water, or crude drug extracts obtained by extraction with water, or in the form of active ingredients of crude drugs. It provides methods of prevention and treatment.
本発明はまた、生薬を、飼料中に配合して投与すること
からなる家畜及び家禽の同疾病の予防及び治療方法を提
供するものである。The present invention also provides a method for preventing and treating the same disease in livestock and poultry, which comprises administering the herbal medicine in feed.
カンゾウ(ロー草)は、カンゾウ(Glye)’rrh
lzaglabra Linne’ var、 gla
ndulif’era Regel etHarder
)の根および根茎をそのまま、またはコルク皮を除いた
ものである。このものは成分としてグリシルリチン、リ
キリチン、ブドウ糖、アスパラギン等を含み、ヒトの緩
和、鎮痙薬、法痰薬として用いられている。Daylily (Glye) 'rrh
lzaglabra Linne' var, gla
ndulif'era Regel et Harder
) roots and rhizomes as they are or with the cork skin removed. This product contains ingredients such as glycyrrhizin, liquiritin, glucose, and asparagine, and is used as a relaxation, antispasmodic, and sputum medicine for humans.
ヨモギ(又)は、ヨモギ(Artemlsia prl
ncepsPampanin+)またはヤマヨモギ(A
、 IlontanaPampanini)の葉である
。このものは成分として、シネオール(50%)の他、
α−ツヨン、セスキテルペン等を含む精油やアルカロイ
ドを含み、ヒトの収れん及び止血薬として子宮出血等に
用い、強壮、補血の効果もある。Mugwort (also known as Artemisia prl)
ncepsPampanin+) or sagebrush (A
, Ilontana Pampanini) leaves. This product has cineole (50%) as an ingredient, as well as
It contains essential oils and alkaloids, including α-thujone and sesquiterpenes, and is used as an astringent and hemostatic agent for uterine bleeding, etc., and also has tonic and blood supplementing effects.
オウレン(黄連)は、オウレン(Coptisjapo
nica Maklno)の根茎から細根を焼去ったも
のである。このものは成分として、ベルベリン、パルマ
チン等を含み、ヒトの健胃苦味、整腸薬として用いられ
ている。Ouren (Yellow Ren) is ouren (Coptisjapo).
It is made by burning off the fine roots from the rhizome of Nica Maklno. This product contains ingredients such as berberine and palmatine, and is used as a bitter and intestinal medicine for humans.
オウゴン(貸手)は、コガネバナ(Scutel Ia
rlabalcalensls Georgj)のコル
ク皮を除いた根である。このものは成分として、オーゴ
ニンとパイカリンを含み、ヒトの消炎、解熱薬として用
いられている。Scutel Ia (lessor) is Scutel Ia.
rlabalcalensls Georgj) from which the cork skin has been removed. This product contains orgonin and picalin as ingredients, and is used as an anti-inflammatory and antipyretic drug for humans.
オウバク(黄柏)は、キハダ(Phel lodend
ronamurense Ruprecht)またはそ
の他の開成他種植物の樹皮のコルク層を除いたものであ
る。このものは成分として、ベルベリン、パルマチン等
を含み、ヒトの健胃、整腸、収れん及び消炎薬として用
いられている。Yellowfin tuna (Pheel rodend)
ronamurense Ruprecht) or other cultivated plants, with the cork layer removed. This product contains berberine, palmatine, etc. as ingredients, and is used as a stomachic, intestinal regulation, astringent, and anti-inflammatory drug for humans.
ゲンノショウコは、ゲンノショウコ(Geranlum
nepalense Swcct)の夏期の茎葉である
。このものは成分して、タンニン、没食子酸、コハク酸
等を含み、ヒトの収れん薬として下痢、腹痛に用いられ
る。Gen no Shoko is Gen no Shoko (Geranlum).
nepalense Swcct) in summer. This substance contains tannins, gallic acid, succinic acid, etc., and is used as an astringent for humans to treat diarrhea and abdominal pain.
コウボク(厚朴)は、ホオノキ(Magnollaob
ovata Thunberg)の樹及び枝の皮である
。このものは成分として、主成分をマチロール、マグノ
ロールとする精油やマグツクマリン等を含み、ヒトの収
れん性利尿、法痰薬として胸腹部の膨満、腹痛及び喘咳
に用いられている。Kouboku is Magnollaob.
It is the bark of the tree and branches of Thunberg ovata. This product contains essential oils whose main components are matyrol and magnolol, as well as magtucoumarin, and is used as an astringent diuretic and sputum medicine for thoracic and abdominal distension, abdominal pain, and wheezing and coughing in humans.
タンジン(丹参)はタンジン(Salvlamiltl
orrhiza Bunge)の根である。このものは
成分として、タンジノンI、■、クリプトタンジノンを
含み、ヒトの強壮、通経、婦人票として月経不調、子宮
出血、腹痛及び諸癒に用いられる。Dangjin (Danjin) is Dangjin (Salvlamiltl).
orrhiza Bunge). This product contains tandinone I, ■, and cryptotandinone as ingredients, and is used for human tonicity, menstruation, and as a feminine aid for menstrual disorders, uterine bleeding, abdominal pain, and various healing.
チモ(知母)は、ハナスゲ(Anemanhenaas
phodclojdcs Bungc)の根茎である。Chimo (Chimo) is Anemanhenaas
phodclojdcs Bungc).
このものは成分としてサポニン、ステロイドサポニン、
タン二ン等を含み、ヒトの消炎、解熱、上湯、利尿、鎮
痛薬として用いられている。This product contains saponin, steroid saponin,
Contains tannin, etc., and is used as an anti-inflammatory, antipyretic, hot bath, diuretic, and analgesic for humans.
ダイオウ(大苗)は、ダイオウ(Rheu■palla
tLIll Linne’またはR,officlna
le Ba1llon)及び近縁植物の根茎の皮部をほ
とんど除去して縦割したものである。このものは成分と
して、アントラキノン誘導体としてのクリソファノール
、エモジン、エモジンモノメチルエーテル等を含み、ヒ
トの健胃苦味、緩下、消炎薬として慢性胃腸病、消化不
良、便秘症に用いられている。The rhubarb (large seedling) is a rhubarb (Rheu palla).
tLIll Linne' or R, officlna
le Balllon) and related plants, with most of the skin removed and the rhizomes vertically divided. This product contains anthraquinone derivatives such as chrysophanol, emodin, and emodin monomethyl ether, and is used to treat chronic gastrointestinal diseases, indigestion, and constipation as a bitter, laxative, and anti-inflammatory drug for humans. .
チョウジ(丁子)は、チョウジ(ELIgenlaca
ryophyllaLa Thunb、)の開花直前の
つぼみである。このものは成分として、オイゲノール、
アセチルオイゲノール等を含み、ヒトの消化機能促進、
駆虫薬として、また香辛料、化粧品としても用いられて
いる。Clove is clove (ELIgenlaca).
This is a bud of ryophylla La Thunb, ) just before flowering. This product contains eugenol,
Contains acetyl eugenol, promotes human digestive function,
It is also used as an anthelmintic, as a spice, and in cosmetics.
ジョテイ(女貞)は、ネズミモチ(L1gustruw
japonicu* Thunberg)の果実である
。このものは成分として、オレアノール酸、ブドウ糖等
を含み、ヒトの強壮薬として用いられている。Jyotei (female chastity) is mouse mochi (L1gustruw)
japonicu* Thunberg). This product contains oleanolic acid, glucose, etc. as ingredients, and is used as a tonic for humans.
ケイガイ(荊芥)は、ケイガイ(Nepetajapo
nica Maxia+owicz)の花期の地上部で
通例長さ3〜5m+sの切片である。このものは成分と
してd−メントン、d−リモネン等を含み、ヒトの発汗
、解熱、解毒薬として用いられる。Keigai (荊芥) is Keigai (Nepetajapo).
It is a section of the above-ground part of the flowering stage of Nica Maxia+owicz, usually 3 to 5 m+s in length. This product contains d-menthone, d-limonene, etc. as ingredients, and is used as a sweat-fighting, fever-reducing, and antidote for humans.
ケイヒ(桂皮)は、ケイジs (C1nna somu
mCassfa Blume)の乾皮及び桂皮を剥ぎコ
ルク層を多少除いたものである。このものは成分として
、シンナムアルデヒド、酢酸シンナミル等を含み、ヒト
の発汗、解熱、鎮痛、健胃、整腸、駆虫薬として用いら
れている。Keihi (Cinnamon) is Keiji s (C1nna somu
mCassfa Blume) with the dried skin and cinnamon bark removed and the cork layer removed to some extent. This product contains cinnamaldehyde, cinnamyl acetate, etc. as ingredients, and is used for human sweating, fever reduction, analgesia, stomach health, intestinal regulation, and as an anthelmintic.
ゲンジン(玄参)は、ゴマノハグサ
(Scrophularia 01dhaIli 01
iver)の根である。ヒトの消炎、解熱、鎮痛及び性
病薬として用いられている。Genjin (Genjin) is Scrophularia 01dhaIli 01
iver) root. It is used in humans as an anti-inflammatory, antipyretic, analgesic, and as a drug for sexually transmitted diseases.
ケツメイシ(決明子)は、エビスグサ(Casslao
btuslrolla Linne’)の成熟した種子
である。Ketsumeishi (Casslao) is Ebisugusa (Casslao).
It is a mature seed of btuslrolla Linne').
このものは成分として、エモジン、オブッシフオリン等
を含み、俗にハブ茶と呼ばれ飲料として茶に代用される
。This product contains ingredients such as emodin and obssifoliin, and is commonly called habu tea and is used as a beverage substitute for tea.
ビワヨウ(批把葉)は、ビワ(Er1obotryaj
aponlca Llndley)の葉の軟毛をできる
だけ除いたものである。このものはブドウ糖、ショ糖、
果糖、マルトース等を成分として含み、ヒトの清涼、健
胃薬として暑気あたりやその予防薬として用いられてい
たものである。Loquat (Er1obotryaj)
aponlca Llndley) from which the hairs of the leaves have been removed as much as possible. This substance is glucose, sucrose,
It contains fructose, maltose, etc. as ingredients, and was used as a refreshing and stomachic medicine for humans and as a preventative against hot weather.
ボウフウ(防風)は、イブキボウフウ(Seselil
lbanotls Koch var、 daucif
olla DC,)の根を根茎とともに乾燥したもので
ある。このものは成分として、精油を含有し、ヒトの発
汗、解熱、鎮痛薬として風邪で頭痛、悪寒、関節痛を伴
う場合に用いられている。Boufuu (windbreak) is Ibukiboufuu (Seselil)
lbanotls Koch var, daucif
olla DC,) is dried along with the rhizome. This product contains essential oils and is used as a sweating, antipyretic, and analgesic for humans when colds are accompanied by headaches, chills, and joint pain.
ホップは、ホップ(Humulus Lupulus
Linne’)の成熟した果糖である。このものは成分
として、タンニン、ツムロン、ルブロン等を含み、ビー
ルの醸造において、苦味および芳香を附けるために必要
なものである。Hops are hops (Humulus Lupulus)
Linne') mature fructose. This product contains tannins, tumurone, rubron, etc. as ingredients, and is necessary for imparting bitterness and aroma in beer brewing.
ソヨウ(蘇葉)は、シソ(Perllla f’rut
escensBrltton var、 acuta
Kudo)の葉である。このものは成分として0.5〜
1%の精油を含み、その55%がペリラアルデヒドで、
その他リモネン、α−ピネン等も含む。ヒトの興奮性発
汗、解熱、鎮咳、鎮痛、鎮静、利尿、健胃薬等として用
いられる。Perilla f'rut
escensBrltton var, acuta
Kudo) leaves. This thing has an ingredient of 0.5~
Contains 1% essential oil, 55% of which is perillaldehyde.
Also includes limonene, α-pinene, etc. It is used for excitatory sweating, antipyretic, antitussive, analgesic, sedative, diuretic, stomachic, etc. in humans.
ヨウバイヒ(揚梅皮)は、ヤマモモ(Myricaru
bra 5iebold at Zuccarinl)
の樹皮である。このものは成分として、タンニン、ミリ
セチン及びミリシトリン等を含み、ヒトの収れん薬とし
て下痢に用い、また打撲症にも効果がある。Youbaihi (fried plum skin) is a Japanese bayberry (Myricaru).
bra 5iebold at Zuccarinl)
It is the bark of the tree. This product contains tannins, myricetin, myricitrin, etc., and is used as an astringent for diarrhea in humans, and is also effective against bruises.
レンギヨウ(連佃)は、レンギヨウ(Forsythi
asuspcnsa Vahl)またはチョウセンレン
ギヨウ(P、 korcanuIIOhvi)の果実で
ある。このものは成分としてオレアノール酸等を含み、
ヒトの解毒、排膿、消炎、利尿薬として用いられている
。Forsythi
asuspcnsa Vahl) or the fruit of Forsythia japonica (P. korcanuIIOhvi). This product contains oleanolic acid etc. as a component,
It is used as a detoxifying, purulent, anti-inflammatory, and diuretic in humans.
アロエは、アロエ(Aloe arborescens
Mill。Aloe is Aloe arborescens.
Mill.
var、 naLalensis Bergel、)の
粘液を煮つめたものである。このものは成分として、バ
ルバロイン、アロエーエモジン等を含み、中東やヨーロ
ッパで非常に古くからヒトの苦味健胃薬または下剤とし
て用いられている。var, naLensis Bergel,) is boiled down. This product contains barbaroin, aloe emodin, etc. as ingredients, and has been used as a bitter stomachic or laxative for humans in the Middle East and Europe since ancient times.
ギュウタン(牛腸)は、ウシ(Bostaurusdo
mesLicus Gselln)の胆のうをぶら下げ
て陰干しするか、または胆管を切開して胆汁を容器に入
れて密封貯蔵したものである。このものは成分として、
コール酸ナトリウム塩、ムコタンパク質、脂肪酸等を含
み、ヒトの黄厄、便秘、糖尿病、痔瘉等の治療に古くか
ら用いられている。Gyutan (cow intestine) is a bovine intestine.
mesLicus Gselln) is hung to dry in the shade, or the bile duct is incised and the bile is sealed and stored in a container. As an ingredient, this
It contains sodium cholate, mucoprotein, fatty acids, etc., and has been used for a long time to treat jaundice, constipation, diabetes, hemorrhoids, etc. in humans.
イレイセン(威霊仙)は、テラセン(CIeIlat1
sMax1a+ovicziana Pranchet
et 5avatler var。Ireisen is Terrasen (CIeIlat1)
sMax1a+ovicziana Ranchet
et 5avatler var.
f’or1da Thunbcrg)または開成近縁植
物の根である。f'or1da Thunbcrg) or the roots of related plants.
このものは成分としてサポニンを含み、ヒトの利尿及び
鎮痛薬として、痛風、リウマチス及び神経痛に用いられ
る。It contains saponin as a component and is used as a diuretic and analgesic in humans for gout, rheumatism and neuralgia.
ウバイ(烏梅)は、ウメ(Prunus Muse 5
ieboldet Zuccarjni)の未熟の果実
から果皮を剥いで煤煙中に埋めて乾燥したものである。Prunus Muse 5
The fruit is peeled off from the unripe fruit of C. ieboldet Zuccarjni and buried in soot to dry.
このものの成分は、コハク酸、クエン酸、リンゴ酸、酒
石酸等であり、ヒトの清涼性収れん薬、上湯、蛎虫駆除
、解熱薬等として用いられる。The ingredients of this product include succinic acid, citric acid, malic acid, tartaric acid, etc., and it is used as a refreshing astringent, a hot bath, a worm exterminator, and an antipyretic for humans.
エンメイソウ(延命草)は、ヒキオコシ(Isodon
japonIca l1ara)またはクロバナヒキ
オコシ(lsodon trichocarpus K
udo)の茎葉である0このものは成分として、プレク
トランチン及びエンメインを含み、ヒトの健胃苦味薬と
して消化不良、食欲不振、腹痛等の治療に用いられる。Enmeiso (Enmeiso) is called Hikiokoshi (Isodon).
japonica l1ara) or black-and-white tree (lsodon trichocarpus K)
Udo) contains plectrantin and enmain as ingredients, and is used as a bitter medicine for human stomach health to treat indigestion, anorexia, abdominal pain, etc.
シャゼンソウ(車前草)は、オウバク
(Plantage asiaLIca Linne’
)の花期の全草である。このものは成分として、アウク
ビン、プランタギニン等を含み、消炎、利尿薬としてヒ
トの眼疾、膀胱炎等に用いられている。Plantage asia LIca Linne'
) is the whole plant in flowering stage. This product contains ingredients such as aucvin and plantaginine, and is used as an anti-inflammatory and diuretic to treat eye diseases, cystitis, etc. in humans.
シンイ(辛夷)は、コブシ(Magnolla Kob
usA、P、 De Candolle)のツボミであ
る。このものは成分として、シトラール、オイゲノール
、シネオール等を含み、芳香薬でヒトの頭痛、癒毒、鼻
疾等に用いられる。Shinyi is Magnolla Kob.
usA, P, De Candolle). This product contains ingredients such as citral, eugenol, and cineole, and is used as an aromatic medicine for headaches, poison healing, nasal disorders, etc.
インチンコウ(d i 、W ’)は、カワラヨモギ(
ArteIIisia capillaris Thu
nberg)の花穂である。Inchinkou (d i , W') is known as Japanese mugwort (d i , W').
ArteIIisia capillaris Thu
nberg).
このものは成分としてカビレン、β−ピベン、カビロン
、カビリンなどのテルペン化合物やイソクマリン体のカ
ピラリン等を含み、ヒトの消炎、解熱、利尿薬として発
熱性の黄痕に有効である。This product contains terpene compounds such as kabiren, β-piben, kabiron, and kabirin, as well as isocoumarin capillarin, and is effective as an anti-inflammatory, antipyretic, and diuretic for humans to treat feverish yellow scars.
ジンコウ(沈香)は、ジンコウ(Aqullarlaa
gallocha Roxb、)の樹脂を含んだ木材で
ある。このものは成分として、ベンジルアセトン、p−
メトキシベンジルアセトン、ヒドロケイ皮酸等を含み、
香木として「香道」の主役をなす材料とされる。また薬
用としては一種の鎮静作用、疲労回復作用を期待して、
喘息、嘔吐、腹痛等に用いられる。Jinko (Agarwood) is called Jinko (Aqullarlaa).
gallocha Roxb,) containing resin. This product contains benzylacetone, p-
Contains methoxybenzylacetone, hydrocinnamic acid, etc.
As a fragrant wood, it is considered to be the main ingredient in ``kodo.'' Also, for medicinal purposes, it is expected to have a kind of sedative effect and fatigue recovery effect.
Used for asthma, vomiting, abdominal pain, etc.
センキュウ(用萼)は、センキュウ(Cnldlumo
f’f1c1nale Maklno)の根を除いた根
茎を通例湯道しして乾燥したものである。このものは成
分としてクニジウムラクトン、クニジウム酸等を含み、
ヒトの浄血、補血、強壮及び鎮静薬として貧血症、冷え
症、月経不順等に用いられている。Cnldlumo
f'f1c1nale Maklno) roots are removed and the rhizomes are usually boiled and dried. This product contains cnidium lactone, cnidic acid, etc. as ingredients,
It is used as a human blood purifier, blood supplement, tonic, and sedative to treat anemia, sensitivity to cold, menstrual irregularities, etc.
コウホン(真木)は、カサモチ(Nothosmyrn
iumjaponiccum Miqucl)の根茎で
ある。このものは成分として、ノトスミルノール、ジメ
トキシアリルベンゼンを主成分とする精油を含有し、ヒ
トの鎮痙、鎮痛薬として用いられている。Kouhon (Maki) is Kasamochi (Nothosmyrn).
It is the rhizome of M.iumjaponiccum Miqucl). This product contains essential oils whose main components are notosmyrnol and dimethoxyallylbenzene, and is used as an antispasmodic and analgesic for humans.
ゴバイシ(五倍子)は、ヌルデノミミフシアブラムシ(
Melaphls chinensls J、 Be1
l)の刺傷により主としてヌルデ(Rhus java
nica Linne’)の葉に生じたゴールであって
、成分としてタンニン、没食子酸、脂肪、樹脂等を含む
。五倍子チンキ、タンニン酸、没食子酸、ピロガロール
の製造原料とされる。Gobaishi (Gobaishi) is the aphid (Nurudenomimifushia aphid)
Melaphls chinensls J, Be1
The sting of Rhus java
It is a gall produced in the leaves of Nica Linne' and contains tannin, gallic acid, fat, resin, etc. as components. It is used as a raw material for the production of five-fold tincture, tannic acid, gallic acid, and pyrogallol.
サンシュユ(山AIA)は、サンシュユ(Cornus
off’1c1na11s 5iebold et Z
ucearini)の成熟した果実から種子を抽いたも
のである。このものは成分として結晶性の有機酸、没食
子酸、リンゴ酸、酒石酸等を含み、ヒトの滋養、強壮、
収れん薬として用いられている。The cornelian cornelian (Mountain AIA) is the cornelian cornelian (Cornus
off'1c1na11s 5iebold et Z
Seeds are extracted from the mature fruits of P. ucearini). This product contains crystalline organic acids, gallic acid, malic acid, tartaric acid, etc. as ingredients, and is nourishing and tonic for humans.
It is used as an astringent.
シコン(紫根)は、ムラサキ(Lithospermu
+*offlcinalc Linne’ var、
erythrorhizonMaxiIlowlcz)
の根である。このものは成分として紫色素アセチルシコ
ニン等を含み、ヒトの解熱、解毒薬として用いられてい
る。Shikon (purple root) is purple root (Lithospermu).
+*offlcinalc Linne' var,
erythrorhizonMaxiIlowlcz)
It is the root of This product contains the purple pigment acetylshikonin, etc., and is used as an antipyretic and antidote for humans.
コオウレン(胡黄連)は、コオウレン
(Plcrorrhiza Kurooa Royle
ex Bench、)の根茎である。このものは成分
として、クトキン、D−マンニトール、バニリン酸等を
含み、ヒトの苦味健胃、緩下剤として用いられている。Plcrorrhiza Kurooa Royle is Plcrorrhiza Kurooa Royle.
ex Bench, ). This product contains ingredients such as kutokin, D-mannitol, and vanillic acid, and is used as a bitter stomachic and laxative for humans.
シャクヤク(荀薬)は、シャクヤク(Paeonlaa
lblf’1ora Pa1las var、 tri
chocarpa Bunge)の根である。成分とし
て安息香酸、樹脂等を含み、ヒトの収れん、緩和、鎮痛
、鎮痙薬として用いられている。Peonies (Xuyaku)
lblf'1ora Pa1las var, tri
chocarpa Bunge). It contains benzoic acid, resin, etc. as ingredients, and is used as an astringent, relaxation, analgesic, and antispasmodic for humans.
キンオウシ(金桜子)は、ナニワイバラ(RosaLa
evigata Michaux)の偽果である。この
ものは成分として、クエン酸、リンゴ酸、タンニン、サ
ポニン、ビタミンC等を含み、ヒトの下痢や多床を止め
るのに用いられている。Kinouushi (Kanaoushi) is called Naniwaibara (RosaLa).
evigata Michaelux). This product contains ingredients such as citric acid, malic acid, tannins, saponins, and vitamin C, and is used to stop diarrhea and multi-bed syndrome in humans.
タイムは、タチジャコウソウ(Thymus vu1g
arlsLinne’)の花期の全草である。このもの
は成分として、チモール、バラシモール、ピネン等を含
み、ヒトの鎮咳薬としてその煎剤またはエキスが用いら
れている。また食品に防腐剤を兼ねた賦香料として用い
られる。Thymus is Thymus vu1g.
arlsLinne') at the flowering stage. This product contains thymol, valathymol, pinene, etc. as ingredients, and its decoction or extract is used as an antitussive for humans. It is also used in food as a flavoring agent that also serves as a preservative.
シロナンテン(白南天)は、Nandlnadowes
tlca Thunb、 var、 Ieucocar
pa Makjnoの果実を乾燥したものである。この
ものは成分として、ドメスチン、プロトビン(アルカロ
イド)等を含み、ヒトの喘息、百日咳などに鎮咳薬とし
て用いられている。White Nanten (White Nanten) is Nandlnadowes
tlca Thunb, var, Ieucocar
It is the dried fruit of pa Makjno. This product contains components such as domesticustin and protobin (alkaloids), and is used as an antitussive for human asthma, whooping cough, etc.
チユ(地楡)は、ワレモコウ(Sangu1sorba
orf’1cina11s L、)の根部を採り、乾燥
したものである。このものは成分として、タンニン(1
7%)、サポニンを含み、ヒトの止血収れん薬として、
吐血、喀血、月経過多に用いられている。Chiyu (earth elm) is Sangu1 sorba (Sangu1 sorba).
orf'1cina11s L,) was harvested and dried. This product contains tannin (1
7%), contains saponin, and is used as a hemostatic astringent for humans.
It is used for hematemesis, hemoptysis, and menstrual bleeding.
マオウ(麻黄)は、マオウ(Ephedra 5lni
caStap(’)の地上茎である。このものは成分と
して、g −エフェドリン、d−シュードエフェドリン
等を含み、ヒトの鎮咳、発汗、利尿薬として用いられて
いる。Ephedra (Ephedra 5lni)
This is the above ground stem of caStap('). This product contains components such as g-ephedrine and d-pseudoephedrine, and is used as an antitussive, diaphoretic, and diuretic for humans.
上記したように、本発明で用いる生薬のカンゾウ、ヨモ
ギ、オウレン、オウゴン、オウバク、ゲンノショウコ、
コウボク、タンジン、チモ、ダイオウ、チョウジ、ジジ
テイ、ケイガイ、ケイヒ、ゲンジン、ケツメイシ、ビワ
ヨウ、ボウフウ、ホップ、ソヨウ、ヨウバイヒ、レンギ
ヨウ、アロエ、ギュウタン、イレイセン、ウバイ、エン
メイソウ、シャゼンソウ、シンイ、インチンコウ、ジン
コウ、センキュウ、コウホン、ゴバイシ、サンシュユ、
シコン、コオウレン、シャクヤク、キンオウシ、タイム
、シロナンテン、チユ及びマオウの夫々は、それらを単
独でか、または組合わせてヒトの疾病の予防及び治療の
ために従来から使用されていたものであるが、これらを
動物の疾病の予防及び治療の目的、殊に動物の感染症の
予防及び治療の目的で使用する試みはこれまでになされ
たことがなかった。As mentioned above, the crude drugs used in the present invention include licorice, mugwort, oren, scutellariae, scutellariae, and
Kouboku, tanjin, chimo, rhubarb, clove, jijitei, keigai, keihi, genjin, ketsumeishi, biwayo, boufuu, hop, soyou, youbaihi, forsythia, aloe, gyutan, ireisen, ubai, japonica, shazenso, shinii, chinko, jinkou, Senkyu, Kouhon, Gobaishi, Cornus,
Citrus elegans, peony, thyme, thyme, cilantro, citrus, and ephedra have traditionally been used alone or in combination for the prevention and treatment of human diseases. No attempt has been made to use these for the prevention and treatment of animal diseases, particularly for the prevention and treatment of infectious diseases in animals.
本発明者らは上記した生薬の薬効に着目して種々研究を
行なった結果、クロストリジウムパーフリンゲンス感染
症、即ち家畜及び家禽がCIostrldluw pe
rfringensに感染することによって発生する疾
病の予防及び治療に上記した生薬の1種または2P!以
上を組合わせて投与することがきわめて有効であること
を見出し、本発明を完成したのである。The present inventors have conducted various studies focusing on the medicinal effects of the above-mentioned herbal medicines, and have found that Clostridium perfringens infection, that is, livestock and poultry
One or two of the above-mentioned herbal medicines for the prevention and treatment of diseases caused by infection with C. rfringens! They have discovered that administering the above in combination is extremely effective, and have completed the present invention.
即ち、下記するように、上記した特定の種類の生薬及び
その抽出物が、インビトロ及びインビボにおいて細菌C
1ostrldiun+ perfrlngensに対
し特異的に静菌作用及び殺菌作用があることが明らかに
なった0そしてこのClostridluIIperf
ringensに対する抑制効果の結果、上記した生薬
を豚に投与した場合にClostrldium per
f’ringensに由来する家畜及び家禽の疾病であ
るクロストリジウム感染症を予防及び冶癒することがで
きたのである。That is, as described below, the above-mentioned specific types of herbal medicines and their extracts are effective against bacterial C in vitro and in vivo.
1 ostrldiun + perfrlngens 0 and this Clostridlu II perf
As a result of the inhibitory effect on C. ringens, when the above-mentioned herbal medicines were administered to pigs, Clostrldium per
It was possible to prevent and cure clostridial infections, which are diseases of livestock and poultry caused by P. f'ringens.
そしてこの家畜及び家禽に特有の疾病に対して上記した
特定のこれら生薬及びその抽出物が有効であることは予
想もしえなかったことで、本発明者らによってはじめて
明らかにされたことである。The effectiveness of the above-mentioned specific herbal medicines and their extracts against diseases specific to livestock and poultry was unexpected and was revealed for the first time by the present inventors.
これら生薬は原末そのまま、または抽出エキス、生薬有
効成分の形態で直接投与したり、またこれらのものを飼
料に添加したりあるいは溶液製剤、分散製剤、半固彩製
剤、粉粒体製剤、成型製剤、浸出製剤、注射用製剤等に
製剤化して使用する。These herbal medicines can be directly administered in the form of raw powder, extracts, or active ingredients of herbal medicines, or they can be added to feed, or they can be prepared in solutions, dispersions, semi-solids, powders or granules, or molded. It is used in formulations such as preparations, infusion preparations, and injection preparations.
抽出エキスは、例えば水、有機溶剤または水と有機溶剤
との混合物を使用して溶剤抽出し、それをそのままか、
濃縮してか、希釈してか、または溶剤を除去して用いら
れる。Extracts can be obtained by solvent extraction, for example using water, an organic solvent, or a mixture of water and an organic solvent, and then left as is, or
It can be used concentrated, diluted, or with the solvent removed.
有機溶剤としては、例えばメタノール、エタノール、n
−プロパツール、n−ブタノール、アセトン、酢酸エチ
ル、エーテル、塩化メチレン、クロロホルム、ベンゼン
、四塩化炭素、石油エーテル等が使用され、特にメタノ
ール、エタノールが望ましい。これらの有機溶剤は1種
または2種以上の混合物として用いることができる。Examples of organic solvents include methanol, ethanol, n
-Propertool, n-butanol, acetone, ethyl acetate, ether, methylene chloride, chloroform, benzene, carbon tetrachloride, petroleum ether, etc. are used, and methanol and ethanol are particularly preferred. These organic solvents can be used alone or as a mixture of two or more.
この溶剤抽出は、生薬をこれらの溶剤に冷浸または温浸
して行なうことができる。冷浸の場合には15〜25℃
、温浸の場合は35〜45℃の温度範囲で行なうことが
できる。抽出時間は、抽出温度によって異なるが、一般
的には約5日間または可溶性成分が充分に溶けるまでと
する。This solvent extraction can be carried out by cold soaking or digesting the herbal medicine in these solvents. 15-25℃ for cold soaking
Digestion can be carried out at a temperature range of 35-45°C. The extraction time varies depending on the extraction temperature, but is generally about 5 days or until the soluble components are sufficiently dissolved.
生薬有効成分は、例えば、上記抽出エキスをさらに各種
溶剤を用いて振盪し、この溶剤に移行する両分を採り出
し、その溶剤を留去したものを有効画分、即ち有効成分
として用いることもできる。The active ingredients of herbal medicines can be obtained by, for example, shaking the above-mentioned extracted extract using various solvents, collecting the fraction that transfers to the solvent, and distilling off the solvent, which can be used as the effective fraction, that is, the active ingredient. can.
この場合に使用される溶剤は、非極性溶剤例えば、低級
脂肪族エーテル類(ジエチルエーテル、エチルメチルエ
ーテル等);低級ハロゲンアルカン類(クロロホルム、
ジクロルエタン、ジブロモエタン等);ベンゼン類(ベ
ンゼン、トルエン、キシレン等);その他の石油系溶剤
(石油エーテル、石油ベンゼン、リグロイン等)等が例
としてあげられる。Solvents used in this case include nonpolar solvents such as lower aliphatic ethers (diethyl ether, ethyl methyl ether, etc.); lower halogen alkanes (chloroform, ethyl methyl ether, etc.);
Examples include dichloroethane, dibromoethane, etc.); benzenes (benzene, toluene, xylene, etc.); and other petroleum solvents (petroleum ether, petroleum benzene, ligroin, etc.).
また、この有効画分を採り出した残りの水溶液を、水及
びある種の有機溶剤に水を飽和させたものを使用するこ
とにより振盪抽出し、水洗し、残分である有機溶剤層に
移行する両分の溶剤を留去したものも、有効画分即ち有
効成分として用いることができる。このH効両分は上記
の有効画分とは、物理化学的性質が異なり、検出される
成分も異なるものである。In addition, the remaining aqueous solution from which this effective fraction was extracted is extracted by shaking using water and a kind of organic solvent saturated with water, washed with water, and transferred to the organic solvent layer that is the residue. A product obtained by distilling off both solvents can also be used as an effective fraction, that is, as an active ingredient. This H-effective fraction has different physicochemical properties and different detected components from the above-mentioned effective fraction.
投与量は、生薬の原末ffi量で換算して0.0011
Ig/体重kg/日〜100g/体重kg/日の範囲で
ある。The dose is 0.0011 in terms of the amount of raw drug ffi.
It ranges from Ig/kg body weight/day to 100 g/kg body weight/day.
この量は予防剤として用いる場合と治療剤として用いる
場合では異なり、一般的には後者の方が投与量は多くな
る。This amount differs depending on whether the drug is used as a prophylactic agent or a therapeutic agent, and the dose is generally higher in the latter case.
投与方法は、経口投与または非経口投与することができ
、非経口投与としては筋肉内投与、腹腔内投与、経皮投
与、経鼻投与、静脈内投与等が可能である。The administration method can be oral or parenteral administration, and examples of parenteral administration include intramuscular administration, intraperitoneal administration, transdermal administration, nasal administration, intravenous administration, and the like.
[発明の効果]
以上詳述したように、本発明によればクロストリジウム
バーフリンゲンス感染症の有効な予防及び治療剤並び
に有効な予防及び治療方法が提供される。[Effects of the Invention] As detailed above, the present invention provides an effective prophylactic and therapeutic agent and an effective prophylactic and therapeutic method for Clostridium verfringens infection.
本発明の予防及び治療剤は生薬またはそれから得られる
エキス等を生薬とするため、抗生物質等の場合の耐性菌
の発生や副作用の問題が全くなく、安心して投与するこ
とができる。Since the prophylactic and therapeutic agent of the present invention uses herbal medicines or extracts obtained from them as herbal medicines, there is no problem of the development of resistant bacteria or side effects associated with antibiotics, etc., and it can be administered with confidence.
また、動物が内用動物、卵及び乳を生産する動物であっ
ても、薬剤の残留による人体への影響の心配もない。Furthermore, even if the animal is a domestic animal or an animal that produces eggs and milk, there is no need to worry about the effects of drug residue on the human body.
さらに、抗生物質等を用いる場合に比べて安価に同疾病
を予防及び治療することができる。Furthermore, the disease can be prevented and treated at a lower cost than when using antibiotics or the like.
以下本発明を試験例及び実施例によりさらに詳しく説明
する。The present invention will be explained in more detail below using test examples and examples.
試験例 I
Clostridium per「ringens
(鳥由来のもの及び豚由来のもの)の各種生薬に対する
感受性を調べた。Test Example I Clostridium per “ringens”
The susceptibility to various herbal medicines (of bird origin and of pig origin) was investigated.
各種生薬を、生薬に対し7倍量の50%エタノール水溶
液中に加え、16時間抽出してアルコール抽出物とした
。Various crude drugs were added to a 50% aqueous ethanol solution in an amount seven times the amount of the crude drugs, and extracted for 16 hours to obtain alcoholic extracts.
抽出物を直径8III11のディスクに25μmずつし
み込ませ乾燥させた。このディスクをCIostrid
1ua+ perf’ringens (鳥由来のも
の及び豚由来のもの)の菌株を塗った6w血液寒天培地
に置き、37℃で18時間培養した後阻止円の直径を測
定した。The extract was infiltrated into a disk of diameter 8III11 by 25 μm and dried. CIostrid this disk
1ua+ perf'ringens (of bird origin and of pig origin) were placed on a 6w blood agar plate and incubated at 37° C. for 18 hours, after which the diameter of the inhibition zone was measured.
次にその試験結果を示せば表1のとおりである。Next, the test results are shown in Table 1.
(以下余白′)
表 1
アルコール抽出物による
カ ン ゾ ウ 18
19ヨ モ ギ In
14オ ウ し ン 22
25オ ウ ゴ ン 17
23オ ウ バ り 17
18ゲンノシヨウコ 1317
コ ウ ボ り エ3
12タ ン ジ ン 17
16チ モ 19
22ダ イ オ ウ tt
12チ ョ ウ ジ
2o 21ジ ョ テ ィ
10 11ケ イ ガ
イ − i。(Margin below) Table 1 Licorice 18 using alcohol extract
19 Yomogi In
14 OWSHIN 22
25 Ougon 17
23 over 17
18 Gennosyouko 1317 Koubori E3
12 Tan Jin 17
16 chimo 19
22 die o tt
12 choji
2o 21joti
10 11 K I G I - i.
ケ イ ヒ 16
15ゲ ン ジ ン −9表
1 (続き)
アルコール抽出物による
ケツメイシ − 9
ビ ョ ワ ウ 13
10ボ ウ フ ウ −9ホ
ッ プ 15 22ソ
ヨ ウ 1o
15ヨウバイヒ 2o23
レンギヨウ 1519
ア ロ エ 9
10ギユウタン 9 20
イレイセン 99
ウ バ イ II
IQエンメイソウ 17 17
シヤゼンソウ 9 10
シ ン イ 9
10インチンコウ 1211
表 1 (続き)
アルコール抽出物による
ン / コ ウ −
9センキユウ 99
コ ウ ホ ン −9ゴ バ イ
シ 20 23サンシユユ
1213
シ コ ン 10
11コオウレン 12 11
シャクヤク 13 13
キンオウシ 14 12
タ イ ム −
11シロナンテン 99
チ ュ 16 1
7マ オ ウ 14 15
(以下余白)
実施例 1
基礎飼料
とうもろこし 450重量部
マ イ ロ
260 〃大 豆 粕
190〃魚 粉 50
/Iイエローグリス 30〃
炭酸カルシウム 7 //第3りん酸カル
シウム 6 〃食 塩
2 〃プレミックス 5
//
前記基礎飼料にオウレン粉末を重量比で0.5%添加し
供試飼料とした。Kei Hi 16
15 Genjin-9 Table
1 (Continued) Ketsumeishi caused by alcohol extract - 9 View 13
10 bow fuu -9 ho
15 22 so
Yo 1o
15 youbaihi 2o23 forengiyo 1519 aroe 9
10 Giyuutan 9 20 Ireisen 99 U Bai II
IQ Enmeiso 17 17 Shazenso 9 10 Shin I 9
10 Inch Kou 1211 Table 1 (Continued) N/Ko by alcohol extract -
9 senkiyu 99 kouhon -9 go by shi 20 23 sanshiyuyu
1213 Sicon 10
11 Kooren 12 11 Peony 13 13 Kingfisher 14 12 Time -
11 Shironanthene 99 Chu 16 1
7 ma ou 14 15
(Left below) Example 1 Basic feed corn 450 parts by weight Milo
260 Soybean meal
190 Fish powder 50
/I yellow grease 30 Calcium carbonate 7 // Tertiary calcium phosphate 6 Salt
2 Premix 5
// 0.5% by weight of Oren powder was added to the basic feed to prepare a test feed.
28日令の健康な鶏760羽に前記供試飼料を自由に摂
餌させた。試験開始から35日間におけるクロストリジ
ウム・バーフリンゲンスの野外感染により死亡した鶏の
羽数を観察した。なお対照区は供試飼料の代わりに基礎
飼料を与えた。760 healthy chickens, 28 days old, were fed the test feed ad libitum. The number of chickens that died due to field infection with Clostridium verfringens during 35 days from the start of the test was observed. In the control group, basal feed was given instead of the test feed.
その結果クロストリジウム・バーフリンゲンス野外感染
で死亡した鶏の開数は本発明の試験区では2羽であった
のに対し、対照区は58羽であった。As a result, the number of chickens that died due to field infection with Clostridium verfringens was 2 in the test plot of the present invention, whereas 58 chickens died in the control plot.
実施例 2〜42
実施例1においてオウレンの代わりに下記表2に示した
生薬を0.6%添加した以外は実施例1と同様に行なっ
た。Examples 2 to 42 The same procedure as in Example 1 was conducted except that 0.6% of the crude drugs shown in Table 2 below was added instead of Oren.
次にその試験結果を示せば表2のとおりである。Next, the test results are shown in Table 2.
表 2
実施例 生薬名 死亡理数(羽)
2 カ ン ゾ ウ 43
ヨ モ ギ 64 オ
ウ ゴ ン 45 オ
ウ バ り 36 ゲンノショウコ
5
7 コ ウ ボ り 58
タ ン ジ ン 39
′ チ モ 2IOダ イ
オ ウ 511 チ ョ
ウ ジ 2表 2 (続き)
実施例 生薬名 死亡理数(羽)
12 ジ ョ テ イ
513 ケ イ ガ イ 3
14 ケ イ ヒ
415 ゲ ン ジ ン
516 ケツメイシ 8
17 ビ ワ ヨ ウ 81
8 ボ ウ フ ウ 819
ホ ッ プ 420
ソ ヨ ウ 521 ヨウ
バイヒ 2
22 レンギヨウ 5
23 7 ロ 二 624
ギュウタン 6
25 イレイセン 8
26 ウ バ イ 52
7 エンメイソウ 3
2B シャゼンソウ 6
表 2 (続き)
例29 シ ン イ
630 インチンコウ 4
31 ジ ン コ ウ 8
32 センキュウ 6
33 コ ウ ホ ン 6
34 ゴ バ イ シ 235
サンシュユ 4
36 シ コ ン
537 コオウレン 4
38 シャクヤク 4
39 キンオウシ 3
40 タ イ ム 8
41 シロナンテン 6
42 チ ュ 343
マ オ ウ 4対 照
58実施例 44
カンゾウ、ヨモギ、オウレン、オウゴン、オウバク、ゲ
ンノショウコ、コウボク、タンジン、チモ、ダイオウ、
チョウジ、ジョテイ、ケイガイ、ケイヒ、ゲンジン、ケ
ツメイシ、ビワヨウ、ボウフウ、ホップ、ソヨウ、ヨウ
バイヒ、レンギヨウ、アロエ、ギュウタン、イレイセン
、ウバイ、エンメイソウ、シャゼンソウ、シンイ、イン
チンコウ、ジンコウ、センキュウ、コウホン、ゴバイシ
、サンシュユ、シコン、コオウレン、シャクヤク、キン
オウシ、タイム、シロナンテン、チユ及びマオウの各々
を1kgとり、これを夫々1047の水に入れ100℃
で1時間抽出した。各々の水抽出物を1000倍に希釈
し抽出エキスとした。Table 2 Examples Crude drug name Mortality (feather) 2 Kanzou 43
Mugwort 64 Ou Gon 45 O
Ubari 36 Genno Shoko 5 7 Koubori 58
Tang Jin 39
' Chimo 2IO Daiou 511 Choji 2 Table 2 (Continued) Examples Herbal medicine name Mortality number (feathers) 12 Jo Tei
513 Kay Guy 3
14 Kei Hi
415 Gen Jin
516 Ketsumeishi 8 17 Biwa Yo 81
8 Bow Fu 819
Hop 420
So You 521 You Baihi 2 22 Forengiyo 5 23 7 Ro 2 624
Gyutan 6 25 Ireisen 8 26 U Bai 52
7 Enmeisou 3 2B Shazenso 6 Table 2 (Continued) Example 29 Shin I
630 Jinko 4 31 Jinko 8
32 Senkyu 6 33 Kouhon 6
34 go by shi 235
Cornelius 4 36 Sikon
537 Koouren 4 38 Peony 4 39 Golden Ox 3 40 Time 8
41 Shironanthene 6 42 Chu 343
Maou 4 comparison
58 Example 44 Licorice, mugwort, oren, scutellariae, scutellariae, gennoshoko, staghorn, tanjin, chimo, rhubarb,
Clove, Jotei, Keigai, Keihi, Genjin, Ketsumeishi, Biwayo, Bofuu, Hop, Soyou, Youbaihi, Forsythia, Aloe, Gyutan, Ireisen, Ubai, Enmeiso, Shazenso, Shinii, Inchinko, Jinko, Senkyu, Kouhon, Gobaishi, Cornus, Take 1 kg of each of Sikon japonica, Oriental japonica, Peony, Ephedra, Thyme, White nanthene, Chiyu, and Ephedra, and add each to 1047 ml of water at 104°C.
Extracted for 1 hour. Each water extract was diluted 1000 times to obtain an extract.
28日令の健康な鶏を485羽使用し、抽出エキスを水
の代わりに給与した。飼料は実施例1で使用したものと
同じ基礎飼料を用いた。また対照区は抽出エキスに代え
て水を与えた。このようにして試験開始から35LI間
飼育しその時のクロストリジウム パーフリンゲンス野
外感染による死亡羽数を観察した。その結果全ての試験
区で対照区よりクロストリジウム パーフリンゲンス感
染による死亡理数が少なかった。485 healthy chickens, 28 days old, were used, and the extract was fed in place of water. The same basal feed as that used in Example 1 was used as the feed. In the control group, water was given instead of the extract. The birds were raised in this way for 35 LI from the start of the test, and the number of dead birds due to Clostridium perfringens field infection was observed at that time. As a result, the number of deaths due to Clostridium perfringens infection was lower in all test plots than in the control plot.
実施例 45
基礎飼料
とうもろこし 450重量部
マ イ ロ
310 〃大 豆 粕
146〃な た ね 粕
30 ”魚 粉
15/l肉 骨 粉
10 llイエローグリス 1
8〃
炭酸カルシウム 5 〃
りん酸カルシウム 8 〃食
塩 3 〃プレミックス
5 1/
前記基礎飼料にオウレン粉末を重量比で0,5%添加し
、供試飼料とした。この供試試料を30日令の健康な豚
50頭に自由に摂餌させ、60日間飼育した。Example 45 Basic feed corn 450 parts by weight Milo
310 Soybean meal
146 kasu
30” fish meal
15/l meat bone powder
10 ll yellow grease 1
8. Calcium carbonate 5. Calcium phosphate 8. Food
Salt 3〃Premix
5 1/ 0.5% by weight of Oren powder was added to the basic feed to prepare a test feed. Fifty healthy pigs, 30 days old, were fed ad libitum with this test sample and raised for 60 days.
また対照区は供試飼料に代えて基礎飼料を与えた。In the control group, basal feed was given instead of the test feed.
そして試験期間中のクロストリジウム バーフリンゲン
ス野外感染で死亡した豚の頭数及びクロストリジウム
バーフリンゲンス野外感染による下痢の延べ日数を観察
した。その結果クロストリジウム バーフリンゲンス野
外感染で死亡した豚の頭数は本発明の試験区では0頭で
あったのに対し、対照区では7頭であった。また試験期
間中に下痢をした豚の延べ頭数は試験区では5頭/30
00頭であったのに対し対照区ではI11頭/ 300
0頭であった。and the number of pigs that died due to Clostridium verfringens field infection during the test period and the number of Clostridium
The total number of days of diarrhea due to field infection with C. burfringens was observed. As a result, the number of pigs that died due to field infection with Clostridium verfringens was 0 in the test area of the present invention, but 7 in the control area. Additionally, the total number of pigs with diarrhea during the test period was 5/30 in the test area.
00 cows, while in the control area I11 cows/300
There were 0 head.
実施例46〜87
実施例45においてオウレン粉末の代わりに下記衣3に
示す生薬を基礎飼料に0.6%添加した以外は実施例4
5と同様に行なった。Examples 46 to 87 Example 4 except that in Example 45, 0.6% of the crude drug shown in Clothing 3 below was added to the basic feed instead of Oren powder.
The same procedure as in step 5 was carried out.
次にその試験結果を示せば表3のとおりである。Next, the test results are shown in Table 3.
(以下余白)
表 3
クロストリジウム バー7
実施例 生薬名 死亡頭数 リンゲンス感染による下痢
豚の延べ頭数×日数
46 カン190150頭 6頭/3000頭47
ヨ モ ギ 0150 8 /
300048 オウゴン0150 5 /3000
49 オウバク0150 6 /300050
ゲンノショウコ 0150 6 /300
051 コウボク0150 7 /300052
タンジン0150 6 /300053 チ
モ 0150 5 /3000
54 ダイオウ0150 7 /300055
チョウジ0150 5 /300056 ジョテイ
0150 7 /300057 ケイガイ0150
8 /300058 ケ イ ヒ 0
150 6 /300059 ゲンジ
ン0150 g /300060 ケツメイシ0
150 8 /300G6■ ビワヨウ0150
7 /30ロ062 ボウフウ0150 8
/s00゜表 3 (続き)
クロストリジウム バー7
実施例 生薬名 死亡頭数 リンゲンス感染による下痢
豚の延べ頭数×日数
63 ホ ツ ブ 0150頭 5頭/
3000頭64 ソ ヨ ウ 0150
7 /300085 ヨウバイヒ01
50 5 /300066 レンギヨウ0150
6 /300067 ア ロ エ
0150 8 /300068 ギュ
ウタン0150 5 /300069 イレイセ
ン0150 8 /30QO70ウ バ
イ 0150 6 /300071
エンメイソウ 0150 7 /30007
2 シャゼンソウ 0150 6 /300
073 シ ン イ 0150
8 /300074 インチンコウ 015
0 7 /300075 ジンコウ0150
B /300076 センキュウ0150
8 /300077 コウホン0150 8 /
300078 ゴバイシ0150 5 /3000
79 サンシュユ0150 7 /3000表
3 (続き)
クロストリジウム バーフ
実施例 生薬名 死亡頭数 リンゲンス感染による下痢
豚の延べ頭数×日数
80 シコン 0150頭 7
/1000頭81 コオウレン 0150
7 /300082 シャクヤク 0
150 7 /300083 キンオウ
シ 0150 6 /300084
タイム 0150 7 /300
085 シロナンテン 0150 8
/30008G チユ 0150
6 /300087 マオウ 0
150 6 /3000対照 715
0 ill /3000(以下余白)
実施例 88
カンゾウ、ヨモギ、オウレン、オウゴン、オウバク、ゲ
ンノショウコ、コウボク、タンジン、チモ、ダイオウ、
チョウジ、ジョテイ、ケイガイ、ケイヒ、ゲンジン、ケ
ツメイシ、ビワヨウ、ボウフウ、ホップ、ソヨウ、ヨウ
バイヒ、レンギヨウ、アロエ、ギュウタン、イレイセン
、ウバイ、エンメイソウ、シャゼンソウ、シンイ、イン
チンコウ、ジンコウ、センキュウ、コウホン、ゴバイシ
、サンシュユ、シコン、コオウレン、シャクヤク、キン
オウシ、タイム、シロナンテン、チユ及びマオウの各々
を1kgとり、これを夫々10gの水に入れ、100℃
で1時間抽出した。各々の水抽出物を1000倍に希釈
し、抽出エキスとした。(Margins below) Table 3 Clostridium bar 7 Example Herbal drug name Number of deaths Total number of pigs with diarrhea due to S. ringens infection x number of days 46 Kan 190,150 6/3000 47
Yomogi 0150 8 /
300048 Scutellariae 0150 5 /3000
49 Oubaku0150 6 /300050
Genno Shoko 0150 6 /300
051 Kouboku0150 7 /300052
Danjin 0150 6 /300053 Chi
Mo 0150 5 /3000
54 Rhubarb 0150 7 /300055
Choji 0150 5 /300056 Jotei 0150 7 /300057 Keigai 0150
8 /300058 Kei Hi 0
150 6 /300059 Genjin 0150 g /300060 Ketsumeishi 0
150 8 /300G6■ Biwayo 0150
7 /30ro 062 Boufuu 0150 8
/s00゜Table 3 (Continued) Clostridium bar 7 Example Herbal drug name Number of dead pigs Total number of pigs with diarrhea due to S. ringens infection x number of days 63 Ho Tubu 0150 pigs 5 pigs/
3000 heads 64 so yo 0150
7 /300085 Youbaihi 01
50 5 /300066 Forsythia 0150
6 /300067 aroe
0150 8 /300068 Gyutan0150 5 /300069 Ireisen0150 8 /30QO70 Uba
I 0150 6 /300071
Enmeiso 0150 7 /30007
2 Shazensou 0150 6 /300
073 Shin Yi 0150
8 /300074 Inchinko 015
0 7 /300075 Jinko 0150
B/300076 Senkyu 0150
8 /300077 Kouhon0150 8 /
300078 Gobaishi0150 5 /3000
79 Cornelius 0150 7/3000 table
3 (Continued) Clostridium barf example Herbal drug name Number of dead pigs Total number of pigs with diarrhea due to S. ringens infection x number of days 80 Shikon 0150 pigs 7
/1000 heads 81 Koouren 0150
7 /300082 Peony 0
150 7 /300083 Kingfish 0150 6 /300084
Time 0150 7 /300
085 Shironanthene 0150 8
/30008G Chuyu 0150
6 /300087 Ephedra 0
150 6 /3000 control 715
0 ill /3000 (blank space below) Example 88 Licorice, mugwort, oren, scutellariae, scutellariae, gennoshoko, scutellariae, tanjin, chimo, rhubarb,
Clove, Jotei, Keigai, Keihi, Genjin, Ketsumeishi, Biwayo, Boufuu, Hop, Soyou, Youbaihi, Forsythia, Aloe, Gyutan, Ireisen, Ubai, Enmeiso, Shazenso, Shinii, Inchinko, Jinko, Senkyu, Kouhon, Gobaishi, Cornus, Take 1 kg of each of Shikon, Oriental laurel, Peony, Golden thyme, Thyme, White nanthene, Chiyu, and Ephedra, add each to 10 g of water, and heat to 100°C.
Extracted for 1 hour. Each water extract was diluted 1000 times to obtain an extract.
30日令の健康な豚を1区50頭使用し、試験区には抽
出エキスを水の代わりに給与し、対照区は水を与えた。Fifty 30-day-old healthy pigs were used in each group, and the test group was given the extract in place of water, and the control group was given water.
飼料は実施例45で使用したものと同じ基礎飼料を用い
た。このようにして60日間飼育し各区のクロストリジ
ウム パーフリンゲンス野外感染による死亡頭数及び下
痢の頭数を観察した。The same basal feed as that used in Example 45 was used as the feed. The animals were raised in this manner for 60 days, and the number of dead animals and the number of animals with diarrhea due to field infection with Clostridium perfringens in each section were observed.
その結果全ての試験区で対照区より死亡頭数及び下痢の
頭数は少なかった。As a result, the number of dead animals and the number of animals with diarrhea were lower in all test plots than in the control plot.
Claims (1)
、ゲンノショウコ、コウボク、タンジン、チモ、ダイオ
ウ、チョウジ、ジョテイ、ケイガイ、ケイヒ、ゲンジン
、ケツメイシ、ビワヨウ、ボウフウ、ホップ、ソヨウ、
ヨウバイヒ、レンギョウ、アロエ、ギュウタン、イレイ
セン、ウバイ、エンメイソウ、シャゼンソウ、シンイ、
インチンコウ、ジンコウ、センキュウ、コウホン、ゴバ
イシ、サンシュユ、シコン、コオウレン、シャクヤク、
キンオウシ、タイム、シロナンテン、チユ及びマオウか
らなる群から選択された1種または2種以上の生薬を含
有する家畜及び家禽のクロストリジウムパーフリンゲン
ス感染症の予防及び治療剤。 2)生薬が原末の形態である特許請求の範囲第1項に記
載の予防及び治療剤。 3)生薬が有機溶剤、水と有機溶剤との混合物または水
で抽出した生薬エキス及び/またはそれから得られた生
薬有効成分である特許請求の範囲第1項に記載の予防及
び治療剤。4)生薬が飼料中に配合されてなる特許請求
の範囲第1項に記載の予防及び治療剤。 5)家畜及び家禽が鶏、豚、牛、羊である特許請求の範
囲第1項に記載の予防及び治療剤。 6)カンゾウ、ヨモギ、オウレン、オウゴン、オウバク
、ゲンノショウコ、コウボク、タンジン、チモ、ダイオ
ウ、チョウジ、ジョテイ、ケイガイ、ケイヒ、ゲンジン
、ケツメイシ、ビワヨウ、ボウフウ、ホップ、ソヨウ、
ヨウバイヒ、レンギョウ、アロエ、ギュウタン、イレイ
セン、ウバイ、エンメイソウ、シャゼンソウ、シンイ、
インチンコウ、ジンコウ、センキュウ、コウホン、ゴバ
イシ、サンシュユ、シコン、コオウレン、シャクヤク、
キンオウシ、タイム、シロナンテン、チユ、マオウから
なる群から選択された1種または2種以上の生薬の有効
量を投与することからなる家畜及び家禽のクロストリジ
ウムパーフリンゲンス感染症の予防及び治療方法。 7)生薬が原末の形態で用いられる特許請求の範囲第6
項に記載の予防及び治療方法。 8)生薬が有機溶剤、水と有機溶剤との混合物または水
で抽出した生薬エキス及び/またはそれから得られた生
薬有効成分である特許請求の範囲第6項に記載の予防及
び治療方法。 9)生薬が飼料に混合して投与される特許請求の範囲第
6項に記載の予防及び治療方法。10)家畜及び家禽が
鶏、豚、牛、羊である特許請求の範囲第6項に記載の予
防及び治療方法。[Scope of Claims] 1) Licorice, mugwort, oren, scutellariae, scutellariae, gennoshoko, kouboku, tanjin, chimo, rhubarb, clove, jotei, keigai, keihi, genjin, ketsumeishi, biwayo, boufu, hop, soyou,
Youbaihi, Forsythia, Aloe, Gyutan, Ireisen, Ubai, Enmeiso, Shazenso, Shinii,
Chinko, Jinkou, Senkyu, Kouhon, Gobaishi, Cornelius, Shikon, Koouren, Peony,
A prophylactic and therapeutic agent for Clostridium perfringens infections in livestock and poultry, which contains one or more herbal medicines selected from the group consisting of goldenrod, thyme, whitenanthene, citrus and ephedra. 2) The prophylactic and therapeutic agent according to claim 1, wherein the crude drug is in the form of bulk powder. 3) The prophylactic and therapeutic agent according to claim 1, wherein the crude drug is an organic solvent, a mixture of water and an organic solvent, a crude drug extract extracted with water, and/or a crude drug active ingredient obtained therefrom. 4) The prophylactic and therapeutic agent according to claim 1, wherein the crude drug is blended into the feed. 5) The prophylactic and therapeutic agent according to claim 1, wherein the livestock and poultry are chickens, pigs, cows, and sheep. 6) Licorice, mugwort, oren, scutellariae, scutellariae, gennoshoko, kouboku, tanjin, chimo, rhubarb, clove, jotei, keigai, keihi, genjin, ketsumeishi, biwayo, boufu, hop, soybean,
Youbaihi, Forsythia, Aloe, Gyutan, Ireisen, Ubai, Enmeiso, Shazenso, Shinii,
Chinko, Jinkou, Senkyu, Kouhon, Gobaishi, Cornelius, Shikon, Koouren, Peony,
A method for preventing and treating Clostridium perfringens infections in livestock and poultry, which comprises administering an effective amount of one or more crude drugs selected from the group consisting of goldenrod, thyme, whitenanthene, citrus, and ephedra. 7) Claim 6 in which the crude drug is used in the form of bulk powder
Prevention and treatment methods described in Section. 8) The prevention and treatment method according to claim 6, wherein the herbal medicine is an organic solvent, a mixture of water and an organic solvent, a herbal medicine extract extracted with water, and/or an active herbal medicine ingredient obtained therefrom. 9) The prevention and treatment method according to claim 6, wherein the herbal medicine is mixed with feed and administered. 10) The prevention and treatment method according to claim 6, wherein the livestock and poultry are chickens, pigs, cows, and sheep.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62328331A JP2599161B2 (en) | 1987-12-26 | 1987-12-26 | Preventive and therapeutic agent for Clostridium perfringens infection in livestock and poultry |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62328331A JP2599161B2 (en) | 1987-12-26 | 1987-12-26 | Preventive and therapeutic agent for Clostridium perfringens infection in livestock and poultry |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01172341A true JPH01172341A (en) | 1989-07-07 |
JP2599161B2 JP2599161B2 (en) | 1997-04-09 |
Family
ID=18209036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62328331A Expired - Lifetime JP2599161B2 (en) | 1987-12-26 | 1987-12-26 | Preventive and therapeutic agent for Clostridium perfringens infection in livestock and poultry |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2599161B2 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01285160A (en) * | 1988-05-12 | 1989-11-16 | Itochu Shiryo Kk | Feed for hog-raising |
EP0394837A2 (en) * | 1989-04-20 | 1990-10-31 | San-A Pharmaceutical Co., Ltd | Feed additive for cultivated fishes and feed for cultivated fishes |
WO2004026041A1 (en) | 2002-09-23 | 2004-04-01 | John I. Haas, Inc. | Hop acids as a replacement for antibiotics in animal feed |
EP1722635A2 (en) | 2004-02-23 | 2006-11-22 | Francis Lloyd Rigby | Feeds containing hop acids and uses thereof as supplements in animal feeds |
CN1327781C (en) * | 2005-08-16 | 2007-07-25 | 长沙绿叶生物科技有限公司 | Health caring feed stuff for healing pig asthma and its using method |
JP2008110951A (en) * | 2006-10-31 | 2008-05-15 | Marubeni Nisshin Feed Co Ltd | Animal feed for preventing and/or treating coccidiosis and clostridium disease |
WO2009047881A1 (en) | 2007-10-12 | 2009-04-16 | Co., Ltd. Kraft | Agent for increasing body weight, animal feed for increasing body weight and health food for increasing body weight |
JP2009089706A (en) * | 2007-10-11 | 2009-04-30 | Jun-Don Lee | Poultry breeding method using environmentally friendly poultry feed |
DE19846432B4 (en) * | 1997-10-10 | 2010-07-08 | S.S. Steiner, Inc. | Use of hops extract as antibiotic |
JP2010538605A (en) * | 2007-09-11 | 2010-12-16 | ディーエスエム アイピー アセッツ ビー.ブイ. | Sesquiterpenes and their derivatives used as feed additives |
EP2397147A1 (en) * | 2008-12-12 | 2011-12-21 | Idemitsu Kosan Co., Ltd. | Feed for preventing and/or treating diseases due to clostridium sp. bacteria in livestock, and anti-clostridium agent |
WO2013059969A1 (en) | 2011-10-28 | 2013-05-02 | Kimberly-Clark Worldwide, Inc. | Sporicidal formulation including botanical extracts/botanical-derived ingredients |
JP2014057591A (en) * | 2007-06-29 | 2014-04-03 | Dsm Ip Assets Bv | Feed additive composition and use thereof |
US9648875B2 (en) | 2011-10-28 | 2017-05-16 | Kimberly-Clark Worldwide, Inc. | Sporicidal formulation including amine oxide surfactant and a mixture of oxidants |
CN108077635A (en) * | 2017-12-22 | 2018-05-29 | 李春慧 | A kind of additive agent for chicken feed and preparation method thereof |
JP2019112363A (en) * | 2017-12-25 | 2019-07-11 | 小林製薬株式会社 | Regulatory t-cell differentiation inhibitor and immunomodulation composition |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006333703A (en) * | 2005-05-06 | 2006-12-14 | Daicho Kikaku:Kk | Animal feed additive and animal feed |
KR101369255B1 (en) * | 2007-03-16 | 2014-03-05 | 원광대학교산학협력단 | A veterinary composition comprising extracts of Galla Rhois and Moutan Cortex Radicis showing antibacterial and antiviral activity |
CN106036153A (en) * | 2016-06-03 | 2016-10-26 | 广西农业职业技术学院 | Chicken feed added with agalloch eaglewood leaf meal |
KR101974924B1 (en) * | 2017-09-13 | 2019-05-03 | (주)이에프씨 | Preparation Method of Drinking Water Composition for Poultry Farming and Drinking Water Composition thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5228922A (en) * | 1975-08-27 | 1977-03-04 | Takeo Ooyama | Medicine mixture for animals |
-
1987
- 1987-12-26 JP JP62328331A patent/JP2599161B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5228922A (en) * | 1975-08-27 | 1977-03-04 | Takeo Ooyama | Medicine mixture for animals |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0466530B2 (en) * | 1988-05-12 | 1992-10-23 | Itochu Shiryo Kk | |
JPH01285160A (en) * | 1988-05-12 | 1989-11-16 | Itochu Shiryo Kk | Feed for hog-raising |
EP0394837A2 (en) * | 1989-04-20 | 1990-10-31 | San-A Pharmaceutical Co., Ltd | Feed additive for cultivated fishes and feed for cultivated fishes |
DE19846432B4 (en) * | 1997-10-10 | 2010-07-08 | S.S. Steiner, Inc. | Use of hops extract as antibiotic |
US8197863B2 (en) | 2002-09-23 | 2012-06-12 | John I. Haas, Inc. | Hop acids as a replacement for antibiotics in animal feed |
WO2004026041A1 (en) | 2002-09-23 | 2004-04-01 | John I. Haas, Inc. | Hop acids as a replacement for antibiotics in animal feed |
US7090873B2 (en) | 2002-09-23 | 2006-08-15 | John I. Haas, Inc. | Hop acids as a replacement for antibiotics in animal feed |
EP2606742A1 (en) * | 2002-09-23 | 2013-06-26 | John I. Haas, Inc. | An animal feed comprising hop acid |
US9084432B2 (en) | 2004-02-23 | 2015-07-21 | Sss Acquisition, Llc | Feeds containing hop acids and uses thereof as supplements in animal feeds |
US7553504B2 (en) | 2004-02-23 | 2009-06-30 | Rigby-Segal | Feeds containing hop acids and uses thereof as supplements in animal feeds |
US8012516B2 (en) | 2004-02-23 | 2011-09-06 | Janet Z. Segal, legal representative | Feeds containing hop acids and uses thereof as supplements in animal feeds |
EP1722635A2 (en) | 2004-02-23 | 2006-11-22 | Francis Lloyd Rigby | Feeds containing hop acids and uses thereof as supplements in animal feeds |
CN1327781C (en) * | 2005-08-16 | 2007-07-25 | 长沙绿叶生物科技有限公司 | Health caring feed stuff for healing pig asthma and its using method |
JP2008110951A (en) * | 2006-10-31 | 2008-05-15 | Marubeni Nisshin Feed Co Ltd | Animal feed for preventing and/or treating coccidiosis and clostridium disease |
JP2014057591A (en) * | 2007-06-29 | 2014-04-03 | Dsm Ip Assets Bv | Feed additive composition and use thereof |
JP2010538605A (en) * | 2007-09-11 | 2010-12-16 | ディーエスエム アイピー アセッツ ビー.ブイ. | Sesquiterpenes and their derivatives used as feed additives |
JP2009089706A (en) * | 2007-10-11 | 2009-04-30 | Jun-Don Lee | Poultry breeding method using environmentally friendly poultry feed |
EP2433501A1 (en) | 2007-10-12 | 2012-03-28 | CO., LTD. Kraft | Agent for increasing body weight, animal feed for increasing body weight and health food for increasing body weight |
WO2009047881A1 (en) | 2007-10-12 | 2009-04-16 | Co., Ltd. Kraft | Agent for increasing body weight, animal feed for increasing body weight and health food for increasing body weight |
EP2397147A1 (en) * | 2008-12-12 | 2011-12-21 | Idemitsu Kosan Co., Ltd. | Feed for preventing and/or treating diseases due to clostridium sp. bacteria in livestock, and anti-clostridium agent |
EP2397147A4 (en) * | 2008-12-12 | 2013-03-13 | Idemitsu Kosan Co | Feed for preventing and/or treating diseases due to clostridium sp. bacteria in livestock, and anti-clostridium agent |
US9730971B2 (en) | 2008-12-12 | 2017-08-15 | Idemitsu Kosan Co., Ltd. | Feed for preventing and/or treating diseases caused by clostridium bacterium in livestock, and agent against clostridium |
WO2013059969A1 (en) | 2011-10-28 | 2013-05-02 | Kimberly-Clark Worldwide, Inc. | Sporicidal formulation including botanical extracts/botanical-derived ingredients |
CN103889237A (en) * | 2011-10-28 | 2014-06-25 | 金伯利-克拉克环球有限公司 | Sporicidal formulation including botanical extracts/botanical-derived ingredients |
EP2770837A4 (en) * | 2011-10-28 | 2015-06-17 | Kimberly Clark Co | Sporicidal formulation including botanical extracts/botanical-derived ingredients |
US9648875B2 (en) | 2011-10-28 | 2017-05-16 | Kimberly-Clark Worldwide, Inc. | Sporicidal formulation including amine oxide surfactant and a mixture of oxidants |
CN108077635A (en) * | 2017-12-22 | 2018-05-29 | 李春慧 | A kind of additive agent for chicken feed and preparation method thereof |
JP2019112363A (en) * | 2017-12-25 | 2019-07-11 | 小林製薬株式会社 | Regulatory t-cell differentiation inhibitor and immunomodulation composition |
Also Published As
Publication number | Publication date |
---|---|
JP2599161B2 (en) | 1997-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Edwards et al. | Phytopharmacy: An evidence-based guide to herbal medicinal products | |
US8632828B2 (en) | Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, and preparation method and use thereof | |
JPH01172341A (en) | Preventive and remedy for infectious disease of clostridium perfringens of domestic animal and domestic fowl | |
Mohanty et al. | Ethnoveterinary importance of herbal galactogogues-a review. | |
Zaurov et al. | The medicinal plants of Uzbekistan and Kyrgyzstan | |
JP2599159B2 (en) | Prevention and treatment of bovine mastitis | |
JP3007665B2 (en) | Preventive and therapeutic agent for coronavirus infection and disinfectant | |
JP2603977B2 (en) | Prevention and treatment of Pasteurella haemolytica infection in livestock | |
Boon et al. | The complete natural medicine guide to the 50 most common medicinal herbs | |
JP2535559B2 (en) | Agent for the prevention and treatment of pruritus in fish | |
WO2020155318A1 (en) | Traditional chinese medicine preparation for treatment of bacterial respiratory tract disease in livestock and production technique thereof | |
Bandyopadhyay et al. | Medicinal pteridophytes: ethnopharmacological, phytochemical, and clinical attributes | |
Petrović et al. | Significance and efficacy of triterpene saponin herbal drugs with expectorant action in cough therapy | |
JP2599160B2 (en) | Preventive and therapeutic agent for staphylococcal disease in chickens | |
Franova et al. | Phytotherapy of cough | |
JP2535555B2 (en) | Agent for preventing and treating streptococcal disease in fish | |
Prabhudesai et al. | Psidium guajava: Multipurpose Medicinal Herb | |
JP2599152B2 (en) | Agent for prevention and treatment of pasturellosis in pigs | |
CN103877281A (en) | Pharmaceutical composition for treating chicken colibacillosis, and preparation method thereof | |
JP2535557B2 (en) | Agent for preventing and treating Vibrio alderi infection of fish | |
Gaikwad et al. | Review on phytochemicals and pharmacological profile of Helicteres isora Linn | |
CN108992559A (en) | For preventing and treating the veterinary Chinese medicinal composition and preparation method thereof of anemopyretic cold and viral influenza | |
CN116077584B (en) | Composition for preventing and treating porcine reproductive and respiratory syndrome and application method thereof | |
JP2535556B2 (en) | Agent for prevention and treatment of vibrio disease in fish | |
JP2599157B2 (en) | Preventive and therapeutic agent for swine dysentery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |